Sort   by:  
 Page size 
UnknownSafety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Not available
S-EPMC10183830 | biostudies-literature
UnknownSpatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2.
Not available
S-EPMC11524965 | biostudies-literature
UnknownNeuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
Not available
S-EPMC6636128 | biostudies-literature
UnknownDeep phenotyping in 3q29 deletion syndrome: recommendations for clinical care.
Not available
S-EPMC8105170 | biostudies-literature
UnknownIntensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Not available
S-EPMC6652154 | biostudies-literature
UnknownImproving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.
Not available
S-EPMC9549605 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownNatural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom.
Not available
S-EPMC8111053 | biostudies-literature
UnknownChanges in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.
Not available
S-EPMC9533580 | biostudies-literature
UnknownBrentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Not available
S-EPMC5819601 | biostudies-literature
Sort   by:  
 Page size